Washington: Researchers have identified specific molecules which they claim could block the means by which the deadly HIV spreads by taking away its ability to bind with other proteins.
Using computer simulations, an international team tested more than 100 carbon fullerene, or C60 derivatives to see if they could be used to inhibit a strain of the virus, HIV-1 PR, by attaching themselves to its binding pocket.
"We began thinking about a very simple experiment to calculate the binding efficiency of a molecule in the HIV pocket, then calculate that for a series of molecules, decide which one is best, make that molecule in real life and see if it correlates.
"If it does, then you've got a way to design your ultimate molecule. Our work was the first step in the process. This is interesting as we're tackling an important problem in a very rational way," lead researcher Andrew Barron of Rice University said.
Using simulations to narrow down a collection of fullerenes to find the good ones is "the least time-consuming low-cost procedure for efficient, rational drug design," according to the researchers.
"A long time ago, people noticed C60 fits perfectly into the hydrophobic pocket in HIV, and it has an inhibition effect. It's not particularly strong, but there's potentially a very strong binding effect. The problem is, it's not the perfect unit," Barron said.
In fact, through their "in-silico," or computer-based, calculations, they found two good fits among the fullerene derivatives tested and are now working to enhance their binding properties to get that perfect molecule, one that sticks "like Velcro" to the virus and can be fine-tuned for various strains.
"This is just one component of the problem -- we're not going to cure HIV. The hope is to develop a method for the rapid creation of drugs to address various strains of HIV and other diseases," Barron said.
The findings are published in the 'Journal of Chemical Information and Modeling'.
Using computer simulations, an international team tested more than 100 carbon fullerene, or C60 derivatives to see if they could be used to inhibit a strain of the virus, HIV-1 PR, by attaching themselves to its binding pocket.
"We began thinking about a very simple experiment to calculate the binding efficiency of a molecule in the HIV pocket, then calculate that for a series of molecules, decide which one is best, make that molecule in real life and see if it correlates.
Using simulations to narrow down a collection of fullerenes to find the good ones is "the least time-consuming low-cost procedure for efficient, rational drug design," according to the researchers.
Advertisement
In fact, through their "in-silico," or computer-based, calculations, they found two good fits among the fullerene derivatives tested and are now working to enhance their binding properties to get that perfect molecule, one that sticks "like Velcro" to the virus and can be fine-tuned for various strains.
Advertisement
The findings are published in the 'Journal of Chemical Information and Modeling'.
Advertisement
COMMENTS
Advertisement
US Teen, Who Just Graduated, Paralysed Due To Rare West Nile Infection Can Human Papillomavirus (HPV) Be A Cancer-Worthy Danger? COVID-19 Virus’ Link That Potentially Increases Brain Infection Risk Found, Claims Study Celebrated "Russian Spy" Whale Hvaldimir Found Dead In Norway: Report INDIA's "Hit With Footwear" Protest In Mumbai Over Shivaji Statue Collapse "It's Mom, I Love You": Mother Of Israeli-American Found Dead In Gaza Ukrainian Drones Target Oil Refinery, Power Plants In Moscow, Says Russia Bollywood Romance Is Dead. Long Live Action! Nurse Molested By Patient During Late Night Shift At West Bengal Hospital Track Latest News Live on NDTV.com and get news updates from India and around the world.